Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. - Wikidata - awgldk - TriplyDB

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.

http://www.wikidata.org/entity/Q41066322

about

Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?Enhancing knowledge discovery from cancer genomics data with Galaxy.Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.IκBζ: an emerging player in cancer.Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma.Genetic landscape and deregulated pathways in B-cell lymphoid malignancies.Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential.Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations.Germline mutations predisposing to diffuse large B-cell lymphoma.Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: therapeutic horizons.Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine.Chronic lymphocytic leukaemia genomics and the precision medicine era.Genetic background and evolution of relapses in aggressive B-cell lymphomas.PD-1 inhibition in congenital pigment synthesizing metastatic melanoma.Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits.Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum.VEGF121, is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers.A bio-clinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma.Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples.Genetics of diffuse large B cell lymphoma.Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis.FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy.TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosis.Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma Genetic Alterations of TRAF Proteins in Human Cancers SIRT1 rs3758391 polymorphism and risk of diffuse large B cell lymphoma in a Chinese population

P2860

Q33622342-B06DC440-28DD-4C74-9B94-E68C55842079 Q36317809-EBA36248-8424-4F6E-88E8-15F0F630F797 Q37150016-7621E945-A6D1-47BA-9385-292FDA4C27FA Q37609908-4C14F1CF-CBAA-4CCC-B13F-6B521596F502 Q37662411-2C4F8A04-E6DF-477B-9F04-40C26DA3D6E6 Q37699251-42AF9B09-4A9B-408B-96D8-F2986D6F1C6E Q38669131-6C6052A5-02E9-49B7-B5B6-743C8821079B Q38685006-704E1391-08A8-4710-8FAE-2C9A03F2EDC6 Q38729502-57E128F7-2681-4D58-87BF-6533B12AC171 Q38739035-63D1CAF8-7E92-45F6-BD7B-5C2245466EAD Q38756189-FB1B7B86-7F92-490E-8E57-17CD7A792BA9 Q38790957-B3FCF6E7-3531-416C-98F6-585FB2D6E043 Q38902828-18DE135E-4F59-463E-8ACD-941D7DCE6F64 Q38909384-04A764A0-37AF-41AD-8D8D-38EDDDF6BD99 Q38959472-01DA1C95-5036-48BC-A27A-0DDBDB6129CF Q39263974-ED7904BC-8B09-4C44-B51D-CD0F3D48EAEA Q39336821-461BC314-9EA4-403D-94DD-7F4ED5861725 Q40135647-7A1F38A5-28DC-4F26-AC7E-F1A417433564 Q41620161-63F0A819-B2F8-4D44-ADA9-B1428C0BEF07 Q47152822-34D14330-28C4-4DFB-930A-7041FD3B2405 Q47373475-D190B61D-7834-403F-B7CA-2E2CC207F4B3 Q47447676-41298C59-995B-40BB-B6BA-4761CA8F15C6 Q48191937-34C6A39E-D21E-4271-83CE-97C7D3194694 Q48319540-2E449F0B-84B3-4F0C-B459-4C6836007271 Q52582248-726BDB68-FF74-403F-8B44-170563A5E45B Q53097908-5A40FC01-A574-4DCF-A5DC-D66EAA111BB1 Q53688633-C5340E91-AAF4-4119-A32B-B63B62FF8ADB Q55177617-9D865D7B-4A2F-4C3C-B7A0-40EA3669C6E5 Q57059909-886D1678-CF40-465A-8D7F-CE6563F005E2 Q57191736-14F7AD69-4D3D-4713-93DF-EE133450DE29 Q58120159-7E2E4DE9-74B3-4303-BA8C-73EAEDF01410

P2860

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.

http://www.wikidata.org/entity/Q41066322

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.

@en

type

label

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.

@en

prefLabel

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.

@en

P1433

Q41066322-7C9CEBA5-9C20-4C64-AB4D-929553B4F8A9

P1476

Q41066322-2FFCD0FB-461B-42A4-AA00-E321B6E8789F

P2093

Q41066322-01FD3846-3A4F-4550-AF1D-72FDCF3B04B3

Q41066322-0CA10BB3-9727-48D8-A537-8946DCCBE22F

Q41066322-0CCDF649-0D18-4039-81CB-AF7EAF5F6FF8

Q41066322-11A6BD8C-9E14-4164-953C-147C23870F4C

Q41066322-133C8A30-2D94-4125-A4C4-76ABE5715065

Q41066322-20D9C041-C297-4558-9564-C1ACCA142584

Q41066322-21CEE9E1-FC8C-4C09-A006-8ED87AAA0821

Q41066322-23A19903-3A28-476D-A9CC-B29CC1758C04

Q41066322-336C8CB8-EDE5-44ED-96F4-D4F1603EA716

Q41066322-3F3D7A63-F396-4165-8B63-1B2346941423

P304

Q41066322-2799C341-385E-490C-93C9-625A33C17AD3

P31

Q41066322-126EE38F-3D59-41AF-A0F1-5FEA79B9322D

P356

Q41066322-56722241-49AE-435D-8B2B-5E454CA9E36B

P407

Q41066322-C804E663-824A-4E42-B80B-AD5BAF6ADF51

P433

Q41066322-1833258C-7348-4BF4-9C18-7D14238CFDB0

P478

Q41066322-8278A94F-88D6-4B2A-A43E-8ABDFC15A0E9

P50

Q41066322-04A826AF-7517-4978-8546-35A9643A3CCD

Q41066322-23A86F69-3BB7-4A18-91AA-EB45A25357F8

Q41066322-47FF09D7-3040-4882-BA3A-35F212464144

Q41066322-9151C705-E79B-4F57-BB19-066F2E2A52E8

Q41066322-A6DE7578-04C6-4FC1-9389-01CF068B3CA1

P577

Q41066322-C39B1A9E-55A4-49B3-9893-13162886AE51

P5875

Q41066322-F64BB883-CC1F-4E80-89F9-C6EB7640FA7F

P698

Q41066322-3E7E261D-21B9-4F75-8D38-E8E69EC33079

P356

1078-0432.CCR-15-2123

P1433

Clinical Cancer Research

P1476

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas

@en

P2093

André Constantin

http://www.w3.org/2001/XMLSchema#string

Arezoo Mohajeri

http://www.w3.org/2001/XMLSchema#string

Axel Tosikyan

http://www.w3.org/2001/XMLSchema#string

Caroline Rousseau

http://www.w3.org/2001/XMLSchema#string

David MacDonald

http://www.w3.org/2001/XMLSchema#string

Errol Camlioglu

http://www.w3.org/2001/XMLSchema#string

Jasleen Grewal

http://www.w3.org/2001/XMLSchema#string

Kathleen Klein Oros

http://www.w3.org/2001/XMLSchema#string

Kevin Bushell

http://www.w3.org/2001/XMLSchema#string

Koren K Mann

http://www.w3.org/2001/XMLSchema#string

P304

2290-2300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-15-2123

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Celia Greenwood

Qiang Pan-Hammarström

P577

2015-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

286445487

http://www.w3.org/2001/XMLSchema#string

P698

26647218

http://www.w3.org/2001/XMLSchema#string